Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » OPGX

 - UBBFriend: Email this page to someone!    
Author Topic: OPGX
Hot-Pepper
Member


Member Rated:
4
Icon 1 posted      Profile for Hot-Pepper     Send New Private Message       Edit/Delete Post   Reply With Quote 
This is where to be, but please do your own research first before you consider getting in.
Posts: 602 | From: Minneapolis | Registered: Jul 2009  |  IP: Logged | Report this post to a Moderator
Love the Market
Member


Member Rated:
4
Icon 1 posted      Profile for Love the Market     Send New Private Message       Edit/Delete Post   Reply With Quote 
Why do you like OPGX? I've has a sell in at .0015 for a long time but it
never got over .0009 even with news this week.

Good Luck to us all!

Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003  |  IP: Logged | Report this post to a Moderator
Hot-Pepper
Member


Member Rated:
4
Icon 1 posted      Profile for Hot-Pepper     Send New Private Message       Edit/Delete Post   Reply With Quote 
I like because it will eventaully produce for us, given the statistics in my own opinion. The type of news we had the other day was the kind we would have expected since last August, but the company did not release anything. I guess the company has a PR company now that is advising them, but Iam not sure.... "HOPEFULLY" they will be releasing information to investors going forward, unless they choose not to do so, which in any case shall not benefit investors who wants to act. This is ofcourse the time to buy as per indicators.
Posts: 602 | From: Minneapolis | Registered: Jul 2009  |  IP: Logged | Report this post to a Moderator
Hot-Pepper
Member


Member Rated:
4
Icon 1 posted      Profile for Hot-Pepper     Send New Private Message       Edit/Delete Post   Reply With Quote 
Optigenex Inc. Announces Expansion of AC-11(R) Sales in Japan ThroughIts Exclusive Partner Itochu Corporation

Feb 3, 2010 08:09:35 (ET)


NEW YORK, NY, Feb 03, 2010 (MARKETWIRE via COMTEX) -- Optigenex Inc. (PINKSHEETS: OPGX) announced today the introduction of AC-11(R)-melon, a new oral capsule formulated by its partner, Itochu Corporation, utilizing patented AC-11(R) in combination with GliSODin, a cantaloupe melon extract rich in the vegetable antioxidant enzyme (SOD). The protective benefits of GliSODin, in conjunction with the therapeutic benefits of AC-11(R) to help repair naturally the body's damaged DNA, offer a unique and highly effective combination for cellular wellness to health-conscious consumers*. Japan traditionally has been known for its highly educated and well-informed consumer population, especially in the area of healthy aging. The enthusiastic response to Koyo-sa Japan's rollout of AC-11(R)-melon validates this reputation and constitutes another step forward in the evolution of AC-11(R) as one of the most popular health and wellness technologies in Japan.

Itochu acts in partnership with Optigenex under a Long-Term Exclusive Supply and Trademark Licensing Agreement to market AC-11(R) bulk material and consumer products containing AC-11(R) under sublicenses in Japan and several other Asian countries. To date, the company has introduced AC-11(R) successfully to over 110 companies in the cosmetic and dietary supplement market, with 130 plus products containing AC-11(R) currently being marketed and sold in Japan. AC-11(R) is the patented, all-natural rain forest botanical extract produced by Optigenex that helps the body's natural ability to repair damage to DNA due to multiple causes, including harmful effects of UV radiation (over-exposure to the sun), stress, environmental pollution and other stressors. In its standard bulk powder form, AC-11(R) supplement may be consumed orally or combined with liposomes and other delivery mechanisms for topical application to the skin.

Daniel Zwiren, president and CEO of Optigenex Inc., said, "We are excited about the Koyo-sa's new product and anticipate further expanded growth in sales this year of AC-11(R) to Japan, not only for AC-11(R)-melon but for other AC-11(R) nutraceutical products as our message for cellular wellness and healthy aging continues to take hold with our customers."

Yusuke Itou of Itochu Corporation added, "Koyo-sa is the largest network marketing company in Japan. We are extremely pleased that they have decided to market AC-11(R)-melon and that they recognize the importance of combining synergistic ingredients for new and robust products." Mr. Itou continued, "We fully expect to augment sales and volume of bulk purchases significantly in 2010 and beyond as our customers integrate AC-11(R) into existing products and formulate new products utilizing AC-11(R) as the main ingredient."

About ITOCHU Corporation:

Itochu Corporation is one of Japan's leading trading companies and is engaged in a wide variety of businesses, including food products, personal care products, textiles, technology multimedia, metals, energy, chemicals, forest products, retail and financial services. Itochu has approximately 45,690 employees, maintains over 130 offices and owns over 651 subsidiaries and affiliates around the world. Itochu's sales last year reached 11.58 trillion yen (U.S. $95 billion).

About Optigenex Inc.:

Optigenex Inc. is a formulator, distributor and provider of proprietary next generation skin care, supplements and bulk ingredient featuring as its core product AC-11(R) (formerly known as C-MED-100(R)) a patented, bioactive and water soluble rain forest compound derived from the medicinal herb Uncaria tomentosa. For more information about Optigenex please visit our website: www.optigenex.com

*The statements made in this press release have not been evaluated by the Food and Drug Administration (FDA). The products mentioned herein are not intended to diagnose, treat, cure or prevent any disease.


Contact:
Optigenex Inc.
Dan Zwiren
president and CEO Optigenex Inc.
dzwiren@optigenex.com
201 355 2098


SOURCE: Optigenex Inc.


mailto:dzwiren@optigenex.com

Posts: 602 | From: Minneapolis | Registered: Jul 2009  |  IP: Logged | Report this post to a Moderator
Lockman
Member


Member Rated:
4
Icon 1 posted      Profile for Lockman     Send New Private Message       Edit/Delete Post   Reply With Quote 
http://stockcharts.com/h-sc/ui?s=OPGX&p=D&b=5&g=0&id=p58548083843

--------------------
Let's Go METS!!!

Posts: 3317 | From: CT | Registered: Dec 2006  |  IP: Logged | Report this post to a Moderator
Hot Pepper
Member


Rate Member
Icon 1 posted      Profile for Hot Pepper     Send New Private Message       Edit/Delete Post   Reply With Quote 
Optigenex Inc. Renews Its Agreement With RFI Ingredients forMarketing and Sale of AC-11(R) in Retail and Direct to PhysicianChannels (Financial Terms Were Not Disclosed)

Feb 18, 2010 08:00:41 (ET)


NEW YORK, NY, Feb 18, 2010 (MARKETWIRE via COMTEX) -- Optigenex Inc. (PINKSHEETS: OPGX) announced today the signing with RFI, LLC of a new, non-exclusive Supply and Trademark License Agreement for the territory of North America. The new agreement renews the parties' several year-long business relationship and extends continuing rights to RFI to manufacture and market dietary supplement products containing AC-11(R) (formerly known as C-Med-100(R)). Both parties anticipate that this timely recommitment will reap mutual benefits, as the growing body of AC-11(R) scientific validation recently has opened several new doors for capitalizing on Optigenex's patented technology, especially in the novel field of advanced, oral-based sun care products.

Jeff Wuagneux, President and CEO of RFI, stated, "We are very excited to continue our work with the management of Optigenex to promote the AC-11(R) product into the natural healthcare industry. Over the past several years we have come to value the science behind AC-11(R), and Optigenex's commitment to furthering the clinical validation of the technology. RFI is dedicated to promoting and marketing science based products, and we feel confident that AC-11(R) will have a great impact as a key strategic component in both the oral-based sun care market, as well as the DNA repair and antioxidant categories."

Daniel Zwiren, President and CEO of Optigenex, added, "We are pleased with the opportunity to renew our excellent relationship with RFI. Jeff and his team have demonstrated an impressive understanding and command of the market, as well as a strong loyalty to AC-11(R) technology over the past two years in the direct to physician's channel. The signing of this expanded agreement was an easy decision for us, because RFI in an impressive fashion has grown its business vertically from wholesale ingredient supplier to a finished product, direct to consumer marketing company. We are confident that RFI is positioned to market AC-11(R) on a large scale to health conscious, educated consumers in North America."

About RFI, LLC:

RFI, LLC is a U.S. based (New York, Colorado) Life Science Development and Commercialization Company offering a pipeline of novel compounds and proprietary science-based nutritional bioactive formulas for the food, dietary supplement, practitioner, direct selling and direct to consumer marketing channels.

About Optigenex Inc.:

Optigenex Inc. is a formulator, distributor and provider of proprietary next generation skin care technology, dietary supplements and bulk ingredient featuring AC-11(R) as its core product. AC-11(R) (formerly known as C-MED-100(R)) is a patented, bioactive and water soluble rain forest compound derived from the medicinal herb Uncaria tomentosa. For more information about Optigenex please visit our website: www.optigenex.com

*The statements made in this press release have not been evaluated by the Food and Drug Administration (FDA). The products mentioned herein are not intended to diagnose, treat, cure or prevent any disease.


Dan Zwiren
President and CEO
Optigenex Inc.
dzwiren@optigenex.com
201 355 2098


SOURCE: Optigenex, Inc.


mailto:dzwiren@optigenex.com

Posts: 94 | From: Minneapolis, Mn. 55458 | Registered: Feb 2000  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share